Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Veliparib (ABT-888) in Combination With Cisplatin Plus Gemcitabine in Advanced Biliary, Pancreatic, Urothelial, and Non-small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01282333
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:28.746888+00:00
Published At
2013-07-02T00:00:00+00:00
Record Updated At
2013-07-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Adult Primary Liver Cancer", "Localized Unresectable Adult Primary Liver Cancer", "Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter", "Regional Transitional Cell Cancer of the Renal Pelvis and Ureter", "Stage III Bladder Cancer", "Stage III Pancreatic Cancer", "Stage IIIA Non-small Cell Lung Cancer", "Stage IIIB Non-small Cell Lung Cancer", "Stage IV Bladder Cancer", "Stage IV Non-small Cell Lung Cancer", "Stage IV Pancreatic Cancer", "Transitional Cell Carcinoma of the Bladder", "Unresectable Extrahepatic Bile Duct Cancer", "Unresectable Gallbladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-07-02"
protocolSection.identificationModule.nctId
"NCT01282333"
protocolSection.identificationModule.officialTitle
"Phase I Study of Veliparib (ABT-888) in Combination With Cisplatin Plus Gemcitabine in Advanced Biliary, Pancreatic, Urothelial, and Non-small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Adult Primary Liver Cancer (protocolSection.conditionsModule.conditions)
  • Localized Unresectable Adult Primary Liver Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter (protocolSection.conditionsModule.conditions)
  • Regional Transitional Cell Cancer of the Renal Pelvis and Ureter (protocolSection.conditionsModule.conditions)
  • Stage III Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Transitional Cell Carcinoma of the Bladder (protocolSection.conditionsModule.conditions)
  • Unresectable Extrahepatic Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Unresectable Gallbladder Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.